Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells

Epigenetics

Volumn 7, Issue 12, 2012, Pages 1379-1390

  Fan, Huitao ^a   Zhang, Rui ^a   Tesfaye, Dawit ^a   Tholen, Ernst ^a   Looft, Christian ^a   Hölker, Michael ^a   Schellander, Karl ^a   Cinar, Mehmet Ulas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Epigenetic repression; Myostatin; Pig; Satellite cell; Sulforaphane

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; A 3656; DNA METHYLTRANSFERASE INHIBITOR; HISTONE DEACETYLASE INHIBITOR; MICRORNA; MYOD PROTEIN; MYOSTATIN; S 8044; SULFORAPHANE; T 8552; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DIET SUPPLEMENTATION; EPIGENETICS; GENE EXPRESSION; GENE REPRESSION; GENETIC REGULATION; HISTONE ACETYLATION; IN VITRO STUDY; LIVESTOCK; NEGATIVE FEEDBACK; NONHUMAN; NUCLEOTIDE SEQUENCE; PROMOTER REGION; PROTEIN BINDING; SATELLITE CELL; SIGNAL TRANSDUCTION; SWINE;

EID: 84870733921     PISSN: 15592294     EISSN: 15592308     Source Type: Journal    
DOI: 10.4161/epi.22609     Document Type: Article

References (56)

1. Lunney JK. Advances in swine biomedical model genomics. Int J Biol Sci 2007; 3:179-84; PMID:17384736; http://dx.doi.org/10.7150/ijbs.3.179
2. Wagers AJ, Conboy IM. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell 2005; 122:659-67; PMID:16143100; http://dx.doi.org/10.1016/j. cell.2005.08.021
3. Kuang S, Gillespie MA, Rudnicki MA. Niche regulation of muscle satellite cell self-renewal and differentiation. Cell Stem Cell 2008; 2:22-31; PMID:18371418; http://dx.doi.org/10.1016/j.stem.2007.12.012
4. Guerrero-Beltrán CE, Calderón-Oliver M, Pedraza-Chaverri J, Chirino YI. Protective effect of sulforaphane against oxidative stress: recent advances. Exp Toxicol Pathol 2012; 64:503-8; PMID:21129940; http:// dx.doi.org/10.1016/j.etp.2010.11.005
5. Myzak MC, Karplus PA, Chung FL, Dashwood RH. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004; 64:5767-74; PMID:15313918; http://dx.doi. org/10.1158/0008-5472.CAN-04-1326
6. Myzak MC, Hardin K, Wang R, Dashwood RH, Ho E. Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. Carcinogenesis 2006; 27:811-9; PMID:16280330; http://dx.doi.org/10.1093/carcin/bgi265
7. Myzak MC, Dashwood WM, Orner GA, Ho E, Dashwood RH. Sulforaphane inhibits histone deacetylase in vivo and suppresses tumorigenesis in Apc-minus mice. FASEB J 2006; 20:506-8; PMID:16407454
8. Myzak MC, Tong P, Dashwood WM, Dashwood RH, Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 2007; 232:227-34; PMID:17259330
9. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A 1997; 94:12457-61; PMID:9356471; http:// dx.doi.org/10.1073/pnas.94.23.12457
10. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003; 162:1135-47; PMID:12963705; http://dx.doi. org/10.1083/jcb.200207056
11. Joulia-Ekaza D, Cabello G. The myostatin gene: physiology and pharmacological relevance. Curr Opin Pharmacol 2007; 7:310-5; PMID:17374508; http:// dx.doi.org/10.1016/j.coph.2006.11.011
12. Perdiguero E, Sousa-Victor P, Ballestar E, Muñoz-Cánoves P. Epigenetic regulation of myogenesis. Epigenetics 2009; 4:541-50; PMID:20009536; http:// dx.doi.org/10.4161/epi.4.8.10258
13. Kelly TK, De Carvalho DD, Jones PA. Epigenetic modifications as therapeutic targets. Nat Biotechnol 2010; 28:1069-78; PMID:20944599; http://dx.doi. org/10.1038/nbt.1678
14. Drummond MJ, Glynn EL, Fry CS, Dhanani S, Volpi E, Rasmussen BB. Essential amino acids increase microRNA-499,-208b, and-23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. J Nutr 2009; 139:2279-84; PMID:19828686; http://dx.doi. org/10.3945/jn.109.112797
15. Allen DL, Loh AS. Posttranscriptional mechanisms involving microRNA-27a and b contribute to fastspecific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol 2011; 300:C124-37; PMID:20980549; http://dx.doi. org/10.1152/ajpcell.00142.2010
16. Allen DL, Unterman TG. Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors. Am J Physiol Cell Physiol 2007; 292:C188-99; PMID:16885393; http://dx.doi. org/10.1152/ajpcell.00542.2005
17. Ma K, Mallidis C, Artaza J, Taylor W, Gonzalez-Cadavid N, Bhasin S. Characterization of 5'-regulatory region of human myostatin gene: regulation by dexamethasone in vitro. Am J Physiol Endocrinol Metab 2001; 281:E1128-36; PMID:11701425
18. Krauss RS. Evolutionary conservation in myoblast fusion. Nat Genet 2007; 39:704-5; PMID:17534361; http://dx.doi.org/10.1038/ng0607-704
19. Singh SV, Srivastava SK, Choi S, Lew KL, Antosiewicz J, Xiao D, et al. Sulforaphane-induced cell death in human prostate cancer cells is initiated by reactive oxygen species. J Biol Chem 2005; 280:19911-24; PMID:15764812; http://dx.doi.org/10.1074/jbc. M412443200
20. Pledgie-Tracy A, Sobolewski MD, Davidson NE. Sulforaphane induces cell type-specific apoptosis in human breast cancer cell lines. Mol Cancer Ther 2007; 6:1013-21; PMID:17339367; http://dx.doi. org/10.1158/1535-7163.MCT-06-0494
21. Utriainen P, Liu J, Kuulasmaa T, Voutilainen R. Inhibition of DNA methylation increases follistatin expression and secretion in the human adrenocortical cell line NCI-H295R. J Endocrinol 2006; 188:305-10; PMID:16461556; http://dx.doi.org/10.1677/ joe.1.06392
22. Iezzi S, Cossu G, Nervi C, Sartorelli V, Puri PL. Stagespecific modulation of skeletal myogenesis by inhibitors of nuclear deacetylases. Proc Natl Acad Sci U S A 2002; 99:7757-62; PMID:12032356; http://dx.doi. org/10.1073/pnas.112218599
23. Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, et al. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 2004; 6:673-84; PMID:15130492; http://dx.doi.org/10.1016/ S1534-5807(04)00107-8
24. Gomyo Y, Sasaki J, Branch C, Roth JA, Mukhopadhyay T. 5-aza-2'-deoxycytidine upregulates caspase-9 expression cooperating with p53-induced apoptosis in human lung cancer cells. Oncogene 2004; 23:6779-87; PMID:15273730; http://dx.doi.org/10.1038/ sj.onc.1207381
25. Singh AV, Xiao D, Lew KL, Dhir R, Singh SV. Sulforaphane induces caspase-mediated apoptosis in cultured PC-3 human prostate cancer cells and retards growth of PC-3 xenografts in vivo. Carcinogenesis 2004; 25:83-90; PMID:14514658; http://dx.doi. org/10.1093/carcin/bgg178
26. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004; 20:61-86; PMID:15473835; http://dx.doi.org/10.1146/annurev. cellbio.20.012103.135836
27. Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 2004; 270:19-30; PMID:15136138; http://dx.doi.org/10.1016/j. ydbio.2004.01.046
28. Valencia-Sanchez MA, Liu J, Hannon GJ, Parker R. Control of translation and mRNA degradation by miRNAs and siRNAs. Genes Dev 2006; 20:515-24; PMID:16510870; http://dx.doi.org/10.1101/ gad.1399806
29. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, et al. MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest 2009; 119:2772-86; PMID:19726871; http:// dx.doi.org/10.1172/JCI36154
30. Bell ML, Buvoli M, Leinwand LA. Uncoupling of expression of an intronic microRNA and its myosin host gene by exon skipping. Mol Cell Biol 2010; 30:1937-45; PMID:20154144; http://dx.doi. org/10.1128/MCB.01370-09
31. Bendixen E, Danielsen M, Larsen K, Bendixen C. Advances in porcine genomics and proteomics--a toolbox for developing the pig as a model organism for molecular biomedical research. Brief Funct Genomics 2010; 9:208-19; PMID:20495211; http://dx.doi. org/10.1093/bfgp/elq004
32. Malaguti M, Angeloni C, Garatachea N, Baldini M, Leoncini E, Collado PS, et al. Sulforaphane treatment protects skeletal muscle against damage induced by exhaustive exercise in rats. J Appl Physiol 2009; 107:1028-36; PMID:19713431; http://dx.doi. org/10.1152/japplphysiol.00293.2009
33. Zhou H, Brockington M, Jungbluth H, Monk D, Stanier P, Sewry CA, et al. Epigenetic allele silencing unveils recessive RYR1 mutations in core myopathies. Am J Hum Genet 2006; 79:859-68; PMID:17033962; http://dx.doi.org/10.1086/508500
34. Meeran SM, Patel SN, Tollefsbol TO. Sulforaphane causes epigenetic repression of hTERT expression in human breast cancer cell lines. PLoS One 2010; 5:e11457; PMID:20625516; http://dx.doi. org/10.1371/journal.pone.0011457
35. Hsu A, Wong CP, Yu Z, Williams DE, Dashwood RH, Ho E. Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin Epigenetics 2011; 3:3; PMID:22303414; http:// dx.doi.org/10.1186/1868-7083-3-3
36. Ping Z, Liu W, Kang Z, Cai J, Wang Q, Cheng N, et al. Sulforaphane protects brains against hypoxicischemic injury through induction of Nrf2-dependent phase 2 enzyme. Brain Res 2010; 1343:178-85; PMID:20417626; http://dx.doi.org/10.1016/j. brainres.2010.04.036
37. Dashwood RH, Ho E. Dietary histone deacetylase inhibitors: from cells to mice to man. Semin Cancer Biol 2007; 17:363-9; PMID:17555985; http://dx.doi. org/10.1016/j.semcancer.2007.04.001
38. Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, et al. Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 2004; 10:5271-81; PMID:15297431; http://dx.doi.org/10.1158/1078-0432.CCR-03-0709
39. Lee SJ, Lee YS, Zimmers TA, Soleimani A, Matzuk MM, Tsuchida K, et al. Regulation of muscle mass by follistatin and activins. Mol Endocrinol 2010; 24:1998-2008; PMID:20810712; http://dx.doi. org/10.1210/me.2010-0127
40. Han DS, Huang HP, Wang TG, Hung MY, Ke JY, Chang KT, et al. Transcription activation of myostatin by trichostatin A in differentiated C2C12 myocytes via ASK1-MKK3/4/6-JNK and p38 mitogenactivated protein kinase pathways. J Cell Biochem 2010; 111:564-73; PMID:20568119; http://dx.doi. org/10.1002/jcb.22740
41. Cho JS, Moon YM, Park IH, Um JY, Moon JH, Park SJ, et al. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts. Clin Exp Allergy 2012; 42:872-82; http://dx.doi.org/10.1111/j.1365-2222.2011.03931.x; PMID:22239687
42. Liu X, Wang J, Li R, Yang X, Sun Q, Albrecht E, et al. Maternal dietary protein affects transcriptional regulation of myostatin gene distinctively at weaning and finishing stages in skeletal muscle of Meishan pigs. Epigenetics 2011; 6:899-907; PMID:21597337; http://dx.doi.org/10.4161/epi.6.7.16005
43. Saito Y, Liang G, Egger G, Friedman JM, Chuang JC, Coetzee GA, et al. Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells. Cancer Cell 2006; 9:435-43; PMID:16766263; http://dx.doi.org/10.1016/j.ccr.2006.04.020
44. Wiklund ED, Bramsen JB, Hulf T, Dyrskjøt L, Ramanathan R, Hansen TB, et al. Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. Int J Cancer 2011; 128:1327-34; PMID:20473948; http://dx.doi.org/10.1002/ ijc.25461
45. Scott GK, Mattie MD, Berger CE, Benz SC, Benz CC. Rapid alteration of microRNA levels by histone deacetylase inhibition. Cancer Res 2006; 66:1277-81; PMID:16452179; http://dx.doi.org/10.1158/0008-5472.CAN-05-3632
46. Spiller MP, Kambadur R, Jeanplong F, Thomas M, Martyn JK, Bass JJ, et al. The myostatin gene is a downstream target gene of basic helix-loop-helix transcription factor MyoD. Mol Cell Biol 2002; 22:7066-82; PMID:12242286; http://dx.doi.org/10.1128/ MCB.22.20.7066-7082.2002
47. ZDS. Zentralverband der Deutschen Schweineproduktion (ZDS): Richtlinie für die Stationsprüfung auf Mastleistung, Schlachtkörperwert und Fleischbeschaffenheit beim Schwein. 2003
48. Mau M, Oksbjerg N, Rehfeldt C. Establishment and conditions for growth and differentiation of a myoblast cell line derived from the semimembranosus muscle of newborn piglets. In Vitro Cell Dev Biol Anim 2008; 44:1-5; PMID:18074188; http://dx.doi.org/10.1007/ s11626-007-9069-6
49. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003; 115:787-98; PMID:14697198; http:// dx.doi.org/10.1016/S0092-8674(03)01018-3
50. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000; 132:365-86; PMID:10547847
51. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods 2001; 25:402-8; PMID:11846609; http://dx.doi. org/10.1006/meth.2001.1262
52. Uddin MJ, Cinar MU, Tesfaye D, Looft C, Tholen E, Schellander K. Age-related changes in relative expression stability of commonly used housekeeping genes in selected porcine tissues. BMC Res Notes 2011; 4:441; PMID:22023805; http://dx.doi.org/10.1186/1756-0500-4-441
53. Fan H, Cinar MU, Phatsara C, Tesfaye D, Tholen E, Looft C, et al. Molecular mechanism underlying the differential MYF6 expression in postnatal skeletal muscle of Duroc and Pietrain breeds. Gene 2011; 486:8-14; PMID:21749918; http://dx.doi.org/10.1016/j. gene.2011.06.031
54. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427-31; PMID:12424112; http://dx.doi.org/10.1093/bioinformatics/ 18.11.1427
55. Marshall OJ. PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics 2004; 20:2471-2; PMID:15073005; http://dx.doi.org/10.1093/bioinformatics/ bth254
56. Kumaki Y, Oda M, Okano M. QUMA: quantification tool for methylation analysis. Nucleic Acids Res 2008; 36(Web Server issue):W170-5; PMID:18487274; http://dx.doi.org/10.1093/nar/gkn294